Heres the real reason ........
A Irish Analyst from a Highly Respected Firm has just given Elan a Value assessment and the breakdown shows a target of $3.97 for AZD-103/ELND005 alone over the next 12 months.....
Elan has 414million shares out. That equates to a Market Cap the Analyst used of 2.35billion because Elan only owns 70% of ELND005
Transition owns 30%.....
30% of 2.35billion is 705 million.
With only 23million shares out Transition would equate to a $30.65/share for AZD-103/ELND005 ALONE!!!
This analyst has followed the Alzheimers research from Elan since its infancy and has been BANG ON on her Valuations!!